Natriumthiopental
Also known as thiopental sodium, sodium pentothal, sodium thiopentobarbital, sodium pentothiobarbital, sodium thiopentone, thiopentone sodium, penthiobarbital sodium, monosodium 5-ethyl-5-(1-methylbutyl) thiobarbiturate
Gruppe von Stereoisomeren
Key facts
- Trade names
- Pentothal, others
- Other names
- Truth serum, thiopentone, thiopental
- Ahfs drugs com
- Monograph
- Pregnancy category
- Australia</span>"}]]}'>AU : D
- Routes of administration
- Intravenous , by mouth , rectal
- Drug class
- Barbiturate
- Atc code
- N01AF03 ( WHO ) N05CA19 ( WHO )
- Legal status
- Australia</span>"}]]}'>AU : S4 (Prescription only) Brazil</span>"}]]}'>BR : Class B1 (Psychoactive drugs) Canada</span>"}]]}'>CA : Schedule IV United Kingdom</span>"}]]}'>UK : Class B United States</span>"}]]}'>US : Schedule III
- Protein binding
- 80%
- Metabolism
- Liver
- Metabolites
- Pentobarbital , others
- Onset of action
Article · Deutsch
Thiopental, als Natriumsalz Thiopental-Natrium (auch Natriumthiopental; Handelsnamen Trapanal, Pentothal), ist ein kurz wirksames Hypnotikum (Schlafmittel) aus der Reihe der Barbiturate. Es wurde zu Beginn der 1930er Jahre von Ernest H. Volwiler und Donalee L. Tabern für Abbott Laboratories entwickelt.
Abstract from DBpedia / Wikipedia · CC BY-SA
Gallery (4)
Connections
Categories
AMPA receptor antagonistsChemical articles with multiple CAS registry numbersDrugs developed by AbbVieDrugs developed by PfizerECHA InfoCard ID from WikidataGABAA receptor positive allosteric modulatorsGeneral anestheticsGlycine receptor agonistsHypnoticsKainate receptor antagonistsLethal injection componentsMultiple chemicals in an infobox that need indexing